Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products.
Wockhardt Limited (WOCKPHARMA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The WOCKPHARMA share price is ₹1,947.00 (-1.91% today), with a market capitalisation of ₹316B and a price-to-earnings (P/E) ratio of 77.2. MarketRipple tracks the WOCKPHARMA investment thesis, the ripple-chain impact of market events on Wockhardt Limited, and the Healthcare sector outlook.
Open
₹1,982.00
High
₹1,984.60
Low
₹1,903.10
Prev. Close
₹1,985.00
52W High
₹2,422.30
52W Low
₹1,086.70
Day range
₹1,903.10–₹1,984.60
52-week range
₹1,086.70–₹2,422.30
Volume
668K
P/E
77.2
ROE
7.8%
D/E
0.45
Margin
10.7%
Wockhardt Limited (NSE: WOCKPHARMA) is currently trading at ₹1,947.00 (-1.91%).
Wockhardt Limited's market capitalization is ₹316B.
Wockhardt Limited's price-to-earnings (P/E) ratio is 77.2.
Wockhardt Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).